News

The deal allows Genmab, which received €7.5m upfront payment previously, to develop human antibodies against three central nervous system targets identified by Lundbeck. Lundbeck, which will entirely fund

The CardioSCORE test is a patented diagnostic blood test designed to improve risk prediction of major cardiovascular events beyond traditional risk factor assessments, such as the Framingham Risk

The data has also reported positive clinical response activity in classical Hodgkin Lymphoma (HL) patients, who could be the target population for future studies. Sponsored by the Fondazione

The new facility will support increased workforce as the company moves ahead with five late-stage development programs to commercialize four drug candidates. The 56,412ft² facility forms part of

Chemical-free AMRAP Refuel Paleo Nutrition Bar includes ingredients including raw almond butter, unsweetened coconut, egg white protein powder, raw sesame seeds, raw almond chunks, raw honey, ground cinnamon,

AAV1-FS344 is myostatin inhibitor delivered through gene therapy to increase muscle strength in patients. At present the company is conducting a Phase I/II trial in patients with Becker

The companies have also announced the proposal of Brintellix as the global trade name for vortioxetine. Positive results obtained from six short-term studies and a long-term maintenance study

Canagliflozin, a selective sodium glucose co-transporter 2 inhibitor, blocks the reabsorption of glucose by the kidney, increasing glucose excretion and lowering blood glucose levels. Metformin may be used

Recothrom is a recombinant thrombin approved by the US FDA for use as a topical hemostat to control non-arterial bleeding during surgical procedures. The Medicines Company chairman and